Skip to content

Clinical trials

Neurodegenerative Diseases trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurodegenerative Diseases Country / region: Belgium Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20101
20121
20141
20173
20201
20232
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Terminated4
Active, not recruiting2
Enrolling by invitation2
Recruiting1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
TauRx Therapeutics Ltd2
Vertex Pharmaceuticals Incorporated2
AbbVie1
Alector Inc.1
AstraZeneca1
Bristol-Myers Squibb1
Friedreich's Ataxia Research Alliance1
Genentech, Inc.1
Hasselt University1
KU Leuven1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurodegenerative Diseases14
Alzheimer Disease8
Dementia7
Brain Diseases6
Nervous System Diseases4
Genetic Diseases, Inborn3
Central Nervous System Diseases2
Cognitive Dysfunction2
Frontotemporal Dementia2
Heredodegenerative Disorders, Nervous System2

Trials

Showing 26 to 14 of 14. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.